Patient with previously treated chronic myeloid leukaemia
Haematologist & Pharmacist
A haematologist and a pharmacist consider the later-line treatment options for chronic myeloid leukaemia, including BCR::ABL1 T315I mutation-positive disease, in a case-based discussion.
Nurse specialist & Haematologist
A nurse specialist and a haematologist consider how to best minimize toxicities while maximizing treatment benefit for patients with chronic myeloid leukaemia, in a case-based discussion.
Mr Johan De Munter and Prof. Dr. Andreas Hochhaus consider how to best minimize toxicities while maximizing treatment benefit in a patient with chronic myeloid leukaemia experiencing side effects with a second-line tyrosine kinase inhibitor.Learn more Back to MDT Hub
Pharmacist & Nurse specialist
A pharmacist and a nurse specialist consider strategies to help maximize quality of life for patients with chronic myeloid leukaemia in the later-line setting, in a case-based discussion.
Dr Bee Kim Tan and Mr Johan De Munter consider strategies to help maximize quality of life in a woman with chronic myeloid leukaemia on a second-line tyrosine kinase inhibitor who has psychological comorbidities and wishes to start a family.Learn more Back to MDT Hub
Haematologist, Patient advocate & Nurse specialist
A chronic myeloid leukaemia (CML) patient advocate speaks with a haematologist and a nurse specialist to provide real-life perspectives on how outcomes can be improved in patients with CML.